Subsense
Palo Alto, California, United States · Biotechnology, Health Care, Medical
Subsense, Inc. is a neurotechnology company developing the first non-surgical, nanoparticle-based bidirectional brain-computer interface. Subsense is partnered with leading global neurological research institutions. The company is venture-backed with its global headquarters in Palo Alto, California. It is co-founded by neurotech entrepreneur Tetiana Aleksandrova and serial entrepreneur Artem So
Key facts
- Headquarters
- Palo Alto, California, United States
- Employees
- 5
- Industries
- Biotechnology, Health Care, Medical
- Status
- Private
- Website
- www.subsense-bci.com
- Company page
Recent activity at Subsense
- : Subsense secures $27M in seed funding to develop non-surgical brain-computer interfaces using nasally delivered nanoparticles.
- : Subsense, Inc. secures an additional $10 million in funding, totaling $27 million, led by Golden Falcon Capital to enhance R&D for non-surgical brain-computer interfaces.
- : Subsense, Inc. raised $17M in seed funding led by Golden Falcon Capital to develop a non-surgical brain-computer interface using nanoparticle-based technologies.
Subsense funding history
| Date | Round | Amount |
|---|---|---|
| Sep 2026 | Seed | $27.0M |
| Dec 2025 | Funding Round | $10.0M |
| Feb 2025 | Seed | $17.0M |
Leadership
- Tetiana Aleksandrova, Founder, CEO
- Aleksandra Isaenko, Head of Operations
- Scott Meek, Head of Research and Development
Verified email and direct lines for Subsense’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Subsense files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Subsense in the news
- Subsense: Interview With CEO And Co-Founder Tetiana Aleksandrova About Non-Surgical Brain-Computer Interfaces - Pulse 2.0 (Sep 25, 2026)
- Subsense Defines a New Category of AI-Native NanoBCI, Advancing a New Path to BCIs Without Surgery - Yahoo Finance (Sep 15, 2026)
- AI visionary Ray Kurzweil is joining a Silicon Valley startup developing a brain computer system that involves snorting nanoparticles - Fortune (Sep 03, 2026)
- Brain-computer interface startup Subsense doubles footprint with Mountain View lab - The Business Journals (Mar 13, 2026)
- Subsense emerges with nanoparticle-based brain-computer interface - Longevity.Technology (Feb 19, 2025)
- AI pioneer joins startup that wants you to snort nanoparticles - The Independent (Sep 04, 2026)
- Subsense Expands Financing to $27 Million to Accelerate R&D for Non-Surgical Brain-Computer Interfaces - Business Wire (Dec 11, 2025)
- The Promise and Challenges of Brain–Computer Interfaces - Technology Networks (Mar 17, 2025)
Companies similar to Subsense
- Octin Health · Biotechnology, Health Care, Medical, Medical Device
- Phantom GI · Biotechnology, Health Care, Medical, Medical Device
- Signum Surgical · Biotechnology, Health Care, Medical, Medical Device
- Thubrikar Aortic Valve · Biotechnology, Health Care, Medical, Medical Device
- QTREX Quantum Ltd · Biotechnology, Health Care, Medical, Medical Device
About Subsense: questions and answers
What does Subsense do?
Subsense, Inc. is a neurotechnology company developing the first non-surgical, nanoparticle-based bidirectional brain-computer interface. Subsense is partnered with leading global neurological research institutions. The company is venture-backed with its global headquarters in Palo Alto, California. It is co-founded by neurotech entrepreneur Tetiana Aleksandrova and serial entrepreneur Artem So
Where is Subsense headquartered?
Subsense is headquartered in Palo Alto, California, United States.
How many employees does Subsense have?
Subsense has about 5 employees.
Has Subsense raised funding?
Yes. Fundz has recorded 3 funding events for Subsense. The most recent, Seed of $27.0M, was in Sep 2026.
Who leads Subsense?
Tetiana Aleksandrova is a Founder, CEO at Subsense.
What is the latest news on Subsense?
On Sep 03, 2026, Subsense secures $27M in seed funding to develop non-surgical brain-computer interfaces using nasally delivered nanoparticles.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy